Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-750 in Healthy Adults and Patients With Peripheral Neuropathic Pain
NCT03346330Phase 1Completed
- Sponsor
- Toray Industries
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Peripheral neuropathic pain comparing TRK-750 with Placebo (2 arms). Primary endpoints: Incidence of treatment-emergent adverse events as assessed by CTCAE v4.03, Proportion of subjects with clinically significant changes in laboratory safety tests and 6 more. Started Nov 2017; status: completed.
02
Drugs
TRK-750
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT03346330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346330.